Literature DB >> 34236010

Chronic active lesions: a new MRI biomarker to monitor treatment effect in multiple sclerosis?

Paolo Preziosa1,2, Massimo Filippi1,2,3,4,5, Maria A Rocca1,2,5.   

Abstract

Entities:  

Keywords:  Chronic active lesions; MRI; multiple sclerosis; slowly-evolving lesions; susceptibility-weighted imaging

Mesh：

Substances：

Year:  2021        PMID： 34236010     DOI： 10.1080/14737175.2021.1953983

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  3 in total

1.  Does Ocrelizumab Limit Multiple Sclerosis Progression? Current Evidence from Clinical, MRI, and Fluid Biomarkers.

Authors:  Monica Margoni; Paolo Preziosa; Paola Tortorella; Massimo Filippi; Maria A Rocca
Journal:  Neurotherapeutics       Date:  2022-06-06       Impact factor: 6.088

2.  Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression.

Authors:  Paolo Preziosa; Elisabetta Pagani; Alessandro Meani; Lucia Moiola; Mariaemma Rodegher; Massimo Filippi; Maria A Rocca
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-02-01

Review 3.  Predictive MRI Biomarkers in MS-A Critical Review.

Authors:  Vlad Eugen Tiu; Iulian Enache; Cristina Aura Panea; Cristina Tiu; Bogdan Ovidiu Popescu
Journal:  Medicina (Kaunas)       Date:  2022-03-03       Impact factor: 2.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.